Grigore T. Popa University of Medicine and Pharmacy Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2017
NCT03708458
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Grigore T. Popa University of Medicine and Pharmacy | "GRIGORE T. POPA" UNIVERSITY OF MEDICINE AND PHARMACY IAŞI | Professor Adrian Covic | University of Medicine and Pharmacy "Gr. T. Popa" Iasi, Romania

Active Ingredients

Drugs in Phase 4 Trials (2)

acetylcysteine (mucomyst) (1 trial)

indomethacin (indocin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pancreatitis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2